Share this event on:

  • LinkedIn

Recomend this page

Thank you, we sent your recommendation to the desired recipient.

Sorry, this functionality is not available right now.
Please try with this link. Thank you.

Scholarship in Pediatric Oncology - AIRC Foundation

Scholarship-in-Pediatric-Oncology---AIRC-Foundation-etichetta-ENG-(2)
Laboratorio-Airc-2019-0035

In 2019, UniCredit Foundation, in collaboration with the AIRC Foundation, chose to support with a scholarship a research project on pediatric oncology, in particular on lymphomas, to develop specific pediatric therapies. Some children with oncological pathologies are often treated with adult protocols.

 

The scholarship funded by UniCredit Foundation is annual (possibly renewable for a further two years) and amounts to € 25,000. It was assigned to the researcher Nina Tanaskovic, working at the European Institute of Oncology IRCCS S.r.l. of Milan, for a study on the role that a particular protein (the PCGF6 protein) plays in the regulation of some genes in lymphomas that must be treated with pediatric therapies.

 

The aim of the research is to evaluate and understand the functioning mechanism of the PCGF6 protein, as this could represent a fundamental first step in developing new therapeutic strategies against this type of cancer.

our-partner

The AIRC Foundation

 

The AIRC Foundation - The Italian Association for Cancer Research was established in 1965 thanks to the initiative of some researchers from the Milan Cancer Institute to support cancer research.

The Foundation supports innovative scientific projects, spreads scientific information and promotes the culture of prevention. It has 4.5 million supporters, 20,000 volunteers and 17 regional committees that guarantee about 5,000 researchers the resources to bring the results from the laboratory to the patient as quickly as possible. One of the Foundation's objectives is to grow a new generation of scientists who are dedicated to cancer research in Italy, supporting training experiences at large research institutes, first in Italy and then abroad, to confront with the best cancer research in the world.